Therapy Areas: Diabetes
GSK releases decade-long data on Shingrix efficacy
17 April 2024 - Biopharmaceutical company GSK plc (LSE/NYSE:GSK) on Wednesday announced positive data from the ZOSTER-049 long-term follow-up phase III trial, spanning up to approximately 11 years pos...
Amylyx Pharmaceuticals' AMX0035 shows promising impact on Wolfram syndrome symptoms
10 April 2024 - Amylyx Pharmaceuticals (NASDAQ: AMLX), a developer of new treatments for neurodegenerative disease, on Wednesday released interim data from Phase 2 HELIOS trial showing improvements in...
Pfizer reports positive Phase 3 data for ABRYSVO in adults at risk for RSV disease
9 April 2024 - Biopharmaceutical company Pfizer Inc (NYSE:PFE) on Tuesday announced positive top-line data from the Phase 3 MONeT trial evaluating ABRYSVO in adults aged 18-59 at risk of developing se...
European Patent Office grants new patent to Lifecare
21 March 2024 - Clinical stage medical sensor company Lifecare AS (Euronext Growth Oslo:LIFE) said on Thursday that it has received notification from the European Patent Office (EPO) that it will gran...
Arecor and TRx Biosciences collaborate to develop enhanced oral GLP-1 for diabetes and obesity
12 March 2024 - Biopharmaceutical group Arecor Therapeutics plc (AIM: AREC) and drug development company TRx Biosciences Limited announced on Tuesday that the companies have joined forces to formulate...
Insulet's Omnipod 5 outperforms standard pump therapy in RCT
8 March 2024 - Tubeless insulin pump technology specialist Insulet Corporation (NASDAQ:PODD) on Friday reported positive results from its first randomised controlled trial (RCT), demonstrating superio...